Multicenter Trial of Fluoxetine as an Adjunct to Behavioral Smoking Cessation Treatment

The authors evaluated the efficacy of fluoxetine hydrochloride (Prozac; Eli Lilly and Company, Indianapolis, IN) as an adjunct to behavioral treatment for smoking cessation. Sixteen sites randomized 989 smokers to 3 dose conditions: 10 weeks of placebo, 30 mg, or 60 mg fluoxetine per day. Smokers re...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Niaura, Raymond, Spring, Bonnie, Borrelli, Belinda, Hedeker, Donald, Goldstein, Michael G., Keuthen, Nancy, DePue, Judy, Kristeller, Jean, Ockene, Judy, Prochazka, Allan, Chiles, John A., Abrams, David B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2002
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852538/
https://ncbi.nlm.nih.gov/pubmed/12182272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1037//0022-006X.70.4.887
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg